Early access
Sign in
Taking people in United StatesPhase 3

Coenzyme Q10 supplement for veterans with Gulf War illness

Tests coenzyme Q10 against placebo for symptoms in veterans with Gulf War illness.

Key facts

Who runs it
University of California, San Diego
Where
La Jolla, United StatesSee the site
Trial code
Registry title
Coenzyme Q10 for Gulf War Illness: A Replication Study
Status
Recruiting
Phase
Phase 3
People taking part
192 people, planned
Started
13 Sept 2024
Expected to end
Dec 2027
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • PharmaNord Bio-Quinone Active CoQ10 Gold 100mg
  • PharmaNord Placebo
Record updated
1 May 2026

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Meets both CDC and Kansas deployment and symptom inclusion criteria
  • Does not have a disqualifying condition
  • Able to travel to a local Quest facility for study blood draws
  • Adequate internet access to allow ZoomPro visit participation and remote survey completion
  • Health prior to the Gulf War rated as "very good" or "excellent" (to exclude persons who may have had other health conditions with different mechanisms as the cause of their symptoms)
  • Willing to defer initiation of discretionary treatments or supplements during the expected course of study participation

Who cannot take part

  • Still-evolving adverse effects following another medication or health condition, such as covid or fluoroquinolone use
  • Participating in another clinical trial
  • On Coumadin/ warfarin
  • Unable to participate for the required duration of the study

Where in United States

  • UC San DiegoLa Jolla, United StatesContact: Janis B. Ritchie, BSNTaking people

About the trial

What the trial wants to find out

The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.

The 3 groups in the trial

  • CoQ10 Arm 1Existing treatment, for comparison

    PharmaNord Ubiquinone 100mg/1x day

    Treatment: PharmaNord Bio-Quinone Active CoQ10 Gold 100mg

  • CoQ10 Arm 2Existing treatment, for comparison

    PharmaNord Ubiquinone 100mg/3x day

    Treatment: PharmaNord Bio-Quinone Active CoQ10 Gold 100mg

  • Placebo ArmPlacebo, for comparison

    Placebo (made by PharmaNord, matches active treatment)

    Treatment: PharmaNord Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Coenzyme Q10 for Gulf War Illness: A Replication Study
Plain-language title
Coenzyme Q10 supplement for veterans with Gulf War illnessGenerated from the registry record. The registry title is the official one.
Record updated
1 May 2026